The binding of IMP to ribonuclease A

FEBS Journal

Volumn 272, Issue 15, 2005, Pages 3988-4001

  Hatzopoulos, George N ^a   Leonidas, Demetres D ^a   Kardakaris, Rozina ^a   Kobe, Joze ^b   Oikonomakos, Nikos G ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

Author keywords

IMP; Ribonuclease A; Structure assisted inhibitor design; X ray crystallography

Indexed keywords

ADENINE; ADENOSINE PHOSPHATE; ASPARAGINE; GLUTAMIC ACID; GUANOSINE; INOSINE PHOSPHATE; NUCLEIC ACID BASE; PANCREATIC RIBONUCLEASE; RIBONUCLEASE A;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME BINDING; ENZYME INHIBITION; ENZYME SPECIFICITY; HYDROGEN BOND; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY;

ADENOSINE MONOPHOSPHATE; ANIMALS; BINDING SITES; CATTLE; CRYSTALLOGRAPHY, X-RAY; INOSINE MONOPHOSPHATE; LIGANDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASE, PANCREATIC;

EID: 23644455952     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04822.x     Document Type: Article

References (65)

1. Cho S, Beintema JJ & Zhang J (2005) The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85, 208-220.
2. International Human Genome Sequencing Consortium. (2004) Finishing the euchromatic sequence of the human genome. Nature 431, 931-945.
3. Beintema JJ & Kleineidam RG (1998) The ribonuclease A superfamily: general discussion. Cell Mol Life Sci 54, 825-832.
4. Rosenberg HF & Domachowske JB (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70, 691-698.
5. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L & Trulson A (1999) Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 29, 1172-1186.
6. Boix E (2001) Eosinophil cationic protein. Methods Enzymol 341, 287-305.
7. Riordan JF (2001) Angiogenin. Methods Enzymol 341, 263-273.
8. Russo A, Acharya KR & Shapiro R (2001) Small molecule inhibitors of RNase A and related enzymes. Methods Enymol 341, 629-648.
9. Raines RT (1998) Ribonuclease A. Chem Rev 98, 1045-1065.
10. Nogues MV, Moussaoui M, Boix E, Vilanova M, Ribo M & Cuchillo CM (1998) The contribution of noncatalytic phosphate-binding subsites to the mechanism of bovine pancreatic ribonuclease A. Cell Mol Life Sci 54, 766-774.
11. Fontecilla-Camps JC, de Llorens R, Du le, MH & Cuchillo CM (1994) Crystal structure of ribonuclease A·d(ApTpApApG) complex. J Biol Chem 269, 21526-21531.
12. Fisher BM, Grilley JE & Raines RT (1998) A new remote subsite in ribonuclease A. J Biol Chem 273, 34134-34138.
13. Leonidas DD, Shapiro R, Irons LI, Russo N & Acharya KR (1999) Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent-3′,5′-pyrophosphate-linked dinucleotide inhibitor. Biochemistry 38, 10287-10297.
14. Leonidas DD, Chavali GB, Oikonomakos NG, Chrysina ED, Kosmopoulou MN, Vlassi M, Frankling C & Acharya KR (2003) High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors. Protein Sci 12, 2559-2574.
15. Witzel H & Barnard EA (1962) Mechanism and binding sites in the ribonuclease reaction II. Kinetic studies on the first step of the reaction. Biochem Biophys Res Commun 7, 295-299.
16. 4. J Mol Biol 189, 305-327.
17. Zegers I, Macs D, Dao-Thi M-H, Poortmans F, Palmer R & Wyns L (1994) The structures of RNase A complexed with 3′CMP and d(CpA): Active site conformation and conserved water molecules. Protein Sci 31, 2322-2339.
18. Toiron C, Gonzalez C, Bruix M & Rico M (1996) Three-dimensional structure of the complexes of ribonuclease A with 2′,5′-CpA and 3′,5′-d(CpA) in aqueous solution, as obtained by NMR and restrained molecular dynamics. Protein Sci 5, 1633-1647.
19. Richards FM & Wyckoff HW (1973) Ribonuclease S. Atlas of Molecular Structures in Biology Vol. 1 (Philips, D C & Richards, F M, eds). Clarendon, Oxford, UK.
20. Gilliland GL, Dill J, Pechik I, Svensson LA & Sjolin L (1994) The active site of bovine pancreatic ribonuclease: an example of solvent modulated specificity. Protein Pept Lett 1, 60-65.
21. Wodak SY, Liu MY & Wyckoff HW (1977) The structure of cytidilyl (2′,5′) adenosine when bound to pancreatic ribonuclease S. J Mol Biol 116, 855-875.
22. Leonidas DD, Shapiro R, Irons LI, Russo N & Acharya KR (1997) Crystal structures of ribonuclease A complexes with 5′-diphosphoadenosine 3′-phosphate and 5′-diphosphoadenosine 2′-phosphate at 1.7 Å resolution. Biochemistry 36, 5578-5588.
23. Jardine AM, Leonidas DD, Jenkins JL, Park C, Raines RT, Acharya KR & Shapiro R (2001) Cleavage of 3,′5-pyrophosphate-linked dinucleotides by ribonuclease A and Angiogenin. Biochemistry 40, 10262-10272.
24. Russo N & Shapiro R (1999) Potent inhibition of mammalian ribonucleases by 3′,5′-pyrophosphate-linked ucleotides. J Biol Chem 274, 14902-14908.
25. Borkakoti N, Moss DA & Palmer RA (1982) Ribonuclease A: Least squares refinement of structure at 1.45 Å resolution. Acta Crystallogr B 38, 2210-2217.
26. Howlin B, Moss DS & Harris GW (1989) Segmented anisotropic refinement of bovine ribonuclease A by the application of rigid-body tls model. Acta Crystallogr A 45, 851-861.
27. deMel VSJ, Doscher MS, Martin PD & Edwards BFP (1994) The occupancy of two distinct conformations by active-site histidine-119 in crystals of Ribonuclease is modulated by pH. FEBS Lett 349, 155-160.
28. Mazzarella L, Capasso S, Demasi D, Di'Lorenzo G, Mattia CA & Zagari A (1993) Bovine seminal ribonuclease - structure at 1.9 Å resolution. Acta Crystallogr D 49, 389-402.
29. Berisio R, Lamzin VS, Sica F, Wilson KS, Zagari A & Mazzarella L (1999) Protein titration in the crystal state. J Mol Biol 292, 845-854.
30. Fedorov AA, Joseph-McCarthy D, Fedorov E, Sirakova D, Graf I & Almo SC (1996) Ionic interactions in crystalline bovine pancreatic ribonuclease A. Biochemistry 35, 15962-15979.
31. Borkakoti N (1983) The active site of ribonuclease A from the crystallographic studies of ribonuclease-A-inhibitor complexes. Eur J Biochem 132, 89-94.
32. Moodie SL & Thornton JM (1993) A study into the effects of protein binding on nucleotide conformation. Nucleic Acid Res 21, 1369-1380.
33. Lawrence MC & Colman PM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234, 946-950.
34. Irie M, Watanabe H, Ohgi K, Tobe M, Matsumura G, Arata Y, Hirose T & Inayama S (1984) Some evidence suggesting the existence of P2 and B3 sites in the active site of bovine pancreatic ribonuclease A. J Biochem 95, 751-759.
35. Russo N, Shapiro R & Vallee BL (1997) 5′-diphosphoadenosine 3′-phosphate is a potent inhibitor of bovine pancreatic ribonuclease A. Biochem Biophys Res Commun 231, 671-674.
36. Lisgarten JN, Maes D, Wyns L, Aguilar CF & Palmer RA (1995) Structure of the crystalline complex of deoxycytidylyl-3′,5′- Guanosine(3′,5′-Dcpdg) cocrystallized with ribonuclease at 1.9-angstrom resolution. Acta Crystallogr D 51, 767-771.
37. Vitagliano L, Merlino A, Zagari A & Mazzarella L (2000) Productive and nonproductive binding to ribonuclease A: X-ray structure of two complexes with uridylyl(2′,5′)guanosine. Protein Sci 9, 1217-1225.
38. Aguilar CF, Thomas PJ, Moss DS, Mills A & Palmer RA (1991) Novel non-productively bound ribonuclease inhibitor complexes - high resolution X-ray refinement studies on the binding of RNase-A to cytidylyl-2′,5′- guanosine (2′,5′CpG) and deoxycytidylyl-3′,5′-guariosine (3′,5′dCpdG). Biochim Biophys Acta 1118, 6-20.
39. Tarragona-Fiol A, Eggelte HJ, Harbron S, Sanchez E, Taylorson CJ, Ward JM & Rabin BR (1993) Identification by site-directed mutagenesis of amino-acids in the B2 subsite of bovine pancreatic ribonuclease A. Protein Eng 6, 901-906.
40. Aguilar CF, Thomas PJ, Mills A, Moss DS & Palmer RA (1992) Newly observed binding mode in pancreatic ribonuclease. J Mol Biol 224, 265-267.
41. Wlodawer A, Miller M & Sjolin L (1983) Active site of RNase: neutron diffraction study of a complex with uridine vanadate, a transition state analog. Proc Natl Acad Sci USA 80, 3628-3631.
42. Lisgarten JN, Gupta V, Maes D, Wyns L, Zegers I, Palmer RA, Dealwis CG, Aguilar CF & Hemmings AM (1993) Structure of the crystalline complex of cytidylic acid (2′-CMP) with ribonuclease at 1.6 Å resolution. Conservation of solvent sites in RNase-A high resolution structures. Acta Crystallogr D 49, 541-547.
43. del, Cardayre SB & Raines RT (1994) Structural determinants of enzymatic processivity. Biochemistry 33, 6031-6037.
44. del, Cardayre SB & Raines RT (1995) A residue to residue hydrogen bond mediates the nucleotide specificity of ribonuclease A. J Mol Biol 252, 328-336.
45. Parés X, Nogués MV, Llorens R & Cuchillo CM (1991) Structure and function of ribonuclease A binding subsites. Essays Biochem 26, 89-103.
46. Sela M & Anfinsen CB (1957) Some spectrophotometric and polarimetric experiments with ribonuclease. Biochim Biophys Acta 24, 229-235.
47. Boix E, Nikolovski Z, Moiseyev GP, Rosenberg HF, Cuchillo CM & Nogués MV (1999) Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J Biol Chem 274, 15605-15614.
48. Boix E, Nogues MV, Schein CH, Benner SA & Cuchillo CM (1994) Reverse transphosphorylation by ribonuclease A needs an intact (P2) - binding site. Point mutations at Lys 7 and Arg 10 alter the catalytic properties of the enzyme. J Biol Chem 269, 2529-2534.
49. Dixon M (1953) The determination of enzyme inhibitor constants. Biochem J 55, 170-171.
50. Leatherbarrow RJ (1992) Grafit, Version 3.0. Erithacus Software Ltd, Staines, UK.
51. Otwinowski Z & Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. In Methods Enzymol. (Carter, C W J & Sweet, R M, eds), pp. 307-326. Academic Press, New York.
52. French S & Wilson KS (1978) On the treatment of the negative intensity observations. Acta Crystallogr A 34, 517-525.
53. Jones TA, Zou JY, Cowan SW & Kjeldgaard M (1991) Improved methods for building models in electron density maps & the location of errors in these models. Acta Crystallogr A 47, 110-119.
54. Murshudov GN, Vagin AA & Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53, 240-255.
55. Laskowski RA, MacArthur MW, Moss DS & Thornton JM (1993) PROCHECK - A program to check the stereochemical quality of protein structures. J Appl Crystallog 26, 283-291.
56. Hubbard SJ & Thornton JM (1993) NACCESS. Department of Biochemistry and Molecular Biology, University College, London, UK.
57. Kraulis PJ (1991) MOLSCRIPT - A program to produce both detailed & schematic plots of protein structures. J Appl Crystallogr 24, 946-950.
58. Esnouf RM (1997) An extensively modified version of MOLSCRIPT that includes greatly enhanced coloring capabilities. J Mol Graphics Modelling 15, 132-134.
59. Merritt EA & Bacon DJ (1997) RASTER3D: Photorealistic molecular graphics. Methods Enzymol B277, 505-524.
60. Sadowski J & Gasteiger J (1993) From atoms and bonds to 3-dimensional atomic coordinates - automatic model builders. Chem Rev 93, 2567-2581.
61. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, GrosseKunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D 54, 905-921.
62. Brünger AT (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-415.
63. IUPAC-IUB & (JCBN) JCoBN (1983) Symbols for specifying the conformation of polysaccharide chains. Recommendations 1981. Eur J Biochem 131, 5-7.
64. Altona C & Sundaralingam M (1972) Conformational analysis of the sugar ring in nucleosides and nucleotides. A new description using the concept of pseudorotation. J Am Chem Soc 94, 8205-8212.
65. McDonald IK & Thornton JM (1994) Satisfying hydrogen bonding potential in proteins. J Mol Biol 238, 777-793.